Reading ELA? Track it free: the weekly brief, plus an alert if the thesis breaks. No credit card.

QuarterlyIQ Insights · ELA

Price

Price, valuation, and the composite score on the same time axis. Scroll over the price chart to zoom.

Price

Daily closes. Earnings/event dots inline.

Close 2026-06-12

Adjusted daily closes (split & dividend). Scroll over the chart to zoom; click a range to reset.

EarningsMaterial event

What it's worth (estimated)

A consensus fair price across 5 valuation methods, at three horizons. Current price $27.30. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.

12-month· primaryexpensive

$11.06consensus

Range $10.18 – $12.19

vs price: +147% above

Method agreement — · 5 methods

No-growth: today's peer multiple on trailing earnings. The headline read.

3-yearfull

$22.62consensus

Range $19.09 – $26.16

vs price: +21% above

Method agreement — · 2 methods

Embeds projected growth. Leans optimistic by design. Upside context.

5-yearfair

By method

Each method's implied share price per horizon. Provisional rows use a projected (historical-CAGR) growth input rather than analyst or management guidance.

Method	Horizon	Est. price	Multiple	Per-share input	EPS source	Confidence
Peer EV/EBITDA	12M	$10.41	10.9	0.86	TTM	high
Peer P/FCF	12M	$13.07	16.0	0.82	TTM	high
Peer P/E	12M	$11.06	15.8	0.70	TTM	high
Peer P/S	12M	$9.87	0.9	10.61	TTM	high
triangulated	12M

P/E history

Monthly trailing P/E with quartile reference lines.

5 monthly points available

Coming next

A “consensus-then vs. actual-now” overlay is on the way — what our valuation estimate said on a past date versus where the price actually landed.

Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.